Fred Hutchinson Cancer Research Center (FHCRC)

Seattle, Washington 98109-1024

1 studies enrolling now · 5 studies all time

What they study most

Autoimmune Disease, Graft vs Host Disease, High Risk Acute Myeloid Leukemia, Invasive Aspergillosis, Invasive Pulmonary Aspergillosis, Myelodysplastic Syndromes, Primary Refractory Acute Myeloid Leukemia, Relapsed Adult Acute Myeloid Leukemia, Scleroderma, Systemic, Sclerosis

Studies at this site

• Novel Digital Application for Patients With Acute Leukemia — Recruiting now
• Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) — Running, not enrolling
• Scleroderma: Cyclophosphamide or Transplantation — Completed
• A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease — Completed
• VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults — Stopped early